Roche P/E is discounted vs its historical average. All in all, Roche maintained its growth path with sales up 1% to CHF 63.28 billion. Looking at the division, pharmaceutical sales increased by 2% to …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Global Chronic Heart Failure (CHF) Devices Market Market Thriving Worldwide: Investment Campaigns, Trends and Analysis 2023-2028 | IRC - March 21, 2023
- EUR/CHF Price Analysis: Eyes 1.0000 as Credit Suisse’s debacle continues to weigh on Swiss Franc - March 21, 2023
- Partners Group reports continued management fee growth; performance fees in line with guidance; dividend up 12% to CHF 37.00 per share - March 21, 2023
